Drug overdoses surged during the pandemic. Providers are thinking outside the box to combat the opioid crisis

In The News | Oct 21, 2021

Tabula Rasa’s, Robert L. Alesiani, PharmD, BCGP, Chief Pharmacist and Chief Pharmacotherapy Officer is quoted in Fierce Healthcare. Alesiani discusses how MedWise® was created to monitor patients for adverse drug reactions (ADEs) and take into account patients’ genomic background to determine whether their body produces particular metabolic enzymes.

Share this:
Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4